AIOCC Italian Registry on Head and Neck Carcinomas
ConditionHead and Neck Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorItalian Head&Neck Society
About this trial
Multicentre, retrospective and prospective observational study aimed to set-up a clinical Italian registry in order to collect information on carcinoma of the Head and Neck.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients (age ≥ 18 years old) diagnosed with carcinoma of the Head and Neck. The diagnosis should be done or verified by the expert site entering the information about the patient in the registry. Patients diagnosed with sarcomas and lymphomas are excluded.
Patients entering the HCP at any clinical phase of the disease (diagnosis, treatment of primary cancer, treatment of recurrence, treatment of M+ etc.). The HCP will collect information on the entire disease regardless of when it started to manage the patient. The HCP can choose, based on its resources, for how many patients will be able to collect the data.
New patients managed by the HCP from 2021 onwards + patients managed by the HCP, in active follow-up at the hospital
Disqualifiers
None
Trial population
Patients treated or followed for Head and Neck cancer
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
observational-retrospective and prospective
Other interventionobservational-retrospective and prospective
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
types of diagnostic and treatment patterns
To document types of diagnostic and treatment patterns by all stages of disease and frequency, and proportion with which they are used in the different stages of Head and Neck cancer.
Time frame
From the enrollment to the end of the study (5 years)Secondary outcomes
1
proportion of patients in the different stage of disease
To estimate the proportion of patients in the different stage of disease (TNM staging system 8\^ edition) in the overall Head and Neck cancer patient population.
Time frame
From the enrollment to the end of the study (5 years)2
treatment outcomes
To assess treatment outcomes in all patients by stage of disease
Time frame
From the enrollment to the end of the study (5 years)3
patients and disease characteristics
To describe patients and disease characteristics (considering possibility of familiar occurrence).
Time frame
From the enrollment to the end of the study (5 years)4
benchmark values
To find benchmark values for selected indicators (i.e., number of retrieved nodes, surgical complication, etc.) for surgical treatment
Time frame
From the enrollment to the end of the study (5 years)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov